Cerus (CERS) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range
May 5, 2022 4:00 PM EDTGrowth From All Geographic Regions with Results Driven by INTERCEPT Platelet Uptake in the U.S.
Total Revenue of $43.0 Million Grew 46% YoY in the First Quarter
Product Revenue of $37.4 Million Grew 60% YoY in the First Quarter
Increasing Full-Year 2022 Product Revenue Guidance Range from $157-164 Million to $160-165 Million
CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2022.
Recent developments and highlights include:
First quarter 2022 total revenue of $43.0 million, reflecting a... More